Matches in SemOpenAlex for { <https://semopenalex.org/work/W4320149711> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W4320149711 abstract "The fundamental target of the present survey is to explore the clinical impact of resveratrol in treating polycystic ovary syndrome. A number of 104 cases suffering from polycystic ovary syndrome admitted to the hospital from January 2018 to December 2020 were chosen as investigation subjects. The cases were categorized into two groups, namely control and study groups through the random number table technique, with 52 patients in each group. Patients in the group of study were considered to receive 100 % pure resveratrol (once daily, 1000 mg) and cases in the group of control received matched placebo. 3 mo later, the treatment effects of the two groups were scrutinized. Following the treating process, the length of ovary, endometrial thickness and number of sinus follicles in the research group were improved and substantially superior to those in the group of control (all p<0.05). The improvement in menstrual cycle and hair loss in the group of observation was considerably greater than that in the group of control (both p<0.05). Following the treatment, the levels of luteinizing hormone, estradiol and testosterone in the group of observation were less than those in the group of control, with statistically meaningful discrepancies (all p<0.05), but the follicle-stimulating hormone levels had no significant difference. After 3 mo of treating, the expression level of mitofusin-2 in the study group was substantially enhanced in comparison to that in the control group (p<0.05). Resveratrol improved sex hormone levels, menstrual irregularities, hair loss and ovarian function in cases suffering from polycystic ovary syndrome." @default.
- W4320149711 created "2023-02-13" @default.
- W4320149711 creator A5002661071 @default.
- W4320149711 creator A5014041056 @default.
- W4320149711 creator A5014219154 @default.
- W4320149711 creator A5076822663 @default.
- W4320149711 date "2022-01-01" @default.
- W4320149711 modified "2023-10-18" @default.
- W4320149711 title "Clinical Observation of Polycystic Ovary Syndrome Treatment with Resveratrol" @default.
- W4320149711 doi "https://doi.org/10.36468/pharmaceutical-sciences.spl.597" @default.
- W4320149711 hasPublicationYear "2022" @default.
- W4320149711 type Work @default.
- W4320149711 citedByCount "0" @default.
- W4320149711 crossrefType "journal-article" @default.
- W4320149711 hasAuthorship W4320149711A5002661071 @default.
- W4320149711 hasAuthorship W4320149711A5014041056 @default.
- W4320149711 hasAuthorship W4320149711A5014219154 @default.
- W4320149711 hasAuthorship W4320149711A5076822663 @default.
- W4320149711 hasBestOaLocation W43201497111 @default.
- W4320149711 hasConcept C126322002 @default.
- W4320149711 hasConcept C126894567 @default.
- W4320149711 hasConcept C134018914 @default.
- W4320149711 hasConcept C142724271 @default.
- W4320149711 hasConcept C204787440 @default.
- W4320149711 hasConcept C27081682 @default.
- W4320149711 hasConcept C2776816829 @default.
- W4320149711 hasConcept C2777391703 @default.
- W4320149711 hasConcept C2778324911 @default.
- W4320149711 hasConcept C2778575703 @default.
- W4320149711 hasConcept C2779058012 @default.
- W4320149711 hasConcept C2779279165 @default.
- W4320149711 hasConcept C2779279991 @default.
- W4320149711 hasConcept C29456083 @default.
- W4320149711 hasConcept C3018442814 @default.
- W4320149711 hasConcept C42407357 @default.
- W4320149711 hasConcept C511355011 @default.
- W4320149711 hasConcept C71315377 @default.
- W4320149711 hasConcept C71924100 @default.
- W4320149711 hasConcept C98274493 @default.
- W4320149711 hasConceptScore W4320149711C126322002 @default.
- W4320149711 hasConceptScore W4320149711C126894567 @default.
- W4320149711 hasConceptScore W4320149711C134018914 @default.
- W4320149711 hasConceptScore W4320149711C142724271 @default.
- W4320149711 hasConceptScore W4320149711C204787440 @default.
- W4320149711 hasConceptScore W4320149711C27081682 @default.
- W4320149711 hasConceptScore W4320149711C2776816829 @default.
- W4320149711 hasConceptScore W4320149711C2777391703 @default.
- W4320149711 hasConceptScore W4320149711C2778324911 @default.
- W4320149711 hasConceptScore W4320149711C2778575703 @default.
- W4320149711 hasConceptScore W4320149711C2779058012 @default.
- W4320149711 hasConceptScore W4320149711C2779279165 @default.
- W4320149711 hasConceptScore W4320149711C2779279991 @default.
- W4320149711 hasConceptScore W4320149711C29456083 @default.
- W4320149711 hasConceptScore W4320149711C3018442814 @default.
- W4320149711 hasConceptScore W4320149711C42407357 @default.
- W4320149711 hasConceptScore W4320149711C511355011 @default.
- W4320149711 hasConceptScore W4320149711C71315377 @default.
- W4320149711 hasConceptScore W4320149711C71924100 @default.
- W4320149711 hasConceptScore W4320149711C98274493 @default.
- W4320149711 hasIssue "S5" @default.
- W4320149711 hasLocation W43201497111 @default.
- W4320149711 hasOpenAccess W4320149711 @default.
- W4320149711 hasPrimaryLocation W43201497111 @default.
- W4320149711 hasRelatedWork W1971309574 @default.
- W4320149711 hasRelatedWork W1991634850 @default.
- W4320149711 hasRelatedWork W2025304600 @default.
- W4320149711 hasRelatedWork W2045259675 @default.
- W4320149711 hasRelatedWork W2052998204 @default.
- W4320149711 hasRelatedWork W2064034534 @default.
- W4320149711 hasRelatedWork W2073502422 @default.
- W4320149711 hasRelatedWork W2133682560 @default.
- W4320149711 hasRelatedWork W2169932845 @default.
- W4320149711 hasRelatedWork W2411910748 @default.
- W4320149711 hasVolume "84" @default.
- W4320149711 isParatext "false" @default.
- W4320149711 isRetracted "false" @default.
- W4320149711 workType "article" @default.